205 related articles for article (PubMed ID: 21438815)
1. Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.
Agouridis AP; Filippatos TD; Tsimihodimos V; Elisaf MS
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):355-66. PubMed ID: 21438815
[TBL] [Abstract][Full Text] [Related]
2. Combination of fenofibrate with non-statin drug regimens.
Agouridis AP; Filippatos TD; Derdemezis CS; Mikhailidis DP; Elisaf MS
Curr Pharm Des; 2010 Oct; 16(30):3401-16. PubMed ID: 20819059
[TBL] [Abstract][Full Text] [Related]
3. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.
Moon YS; Chun P; Chung S
Drugs Today (Barc); 2007 Jan; 43(1):35-45. PubMed ID: 17315051
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering effects of ezetimibe and simvastatin in combination.
Ijioma N; Robinson JG
Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P
J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657
[TBL] [Abstract][Full Text] [Related]
7. [Combined treatment: regimens, indications and safety profile].
Muñiz Grijalvo O; Villar Ortiz J
Clin Investig Arterioscler; 2013; 25(3):140-5. PubMed ID: 23880257
[TBL] [Abstract][Full Text] [Related]
8. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
9. [Ezetimibe: caution in the face of doubt].
Araujo F; Mateo de Castro J; Encinas Barrios C
Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227
[No Abstract] [Full Text] [Related]
10. Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia.
Jelesoff NE; Ballantyne CM; Xydakis AM; Chiou P; Jones PH; Guyton JR
Endocr Pract; 2006; 12(2):159-64. PubMed ID: 16690463
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
Rodríguez-Ferrero ML; Anaya F
Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
[TBL] [Abstract][Full Text] [Related]
12. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive lipid lowering therapy in the era of surrogate endpoints.
Silverman MG; Blaha MJ; Blumenthal RS
Cardiol Rev; 2011; 19(1):17-22. PubMed ID: 21135598
[TBL] [Abstract][Full Text] [Related]
14. Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.
Zafrir B; Jain M
Cardiovasc Drugs Ther; 2014 Aug; 28(4):361-77. PubMed ID: 24952127
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of hyperlipidemia.
Last AR; Ference JD; Falleroni J
Am Fam Physician; 2011 Sep; 84(5):551-8. PubMed ID: 21888306
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
Kastelein JJ; Sankatsing RR
Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
[TBL] [Abstract][Full Text] [Related]
17. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
Broncel M; Balcerak M; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
[TBL] [Abstract][Full Text] [Related]
18. [Ezetimibe with statins].
Jublanc C; Giral P; Turpin G
Presse Med; 2006 Mar; 35(3 Pt 2):487-94. PubMed ID: 16550148
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
